MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) Fair Value & Analysis
Healthcare · IN · Market cap ₹28.1B
Fair value as of: Aug 13, 2026
From 26 valuation models · updated 4 days ago
Share price −3.6% over the past month.
Below-average quality, and screening another 34% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹281.58). The favourable scenario is already priced in.
- Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹133.97 to ₹281.58) leaves room in how you read the outcome.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
31‑month range ₹296.75 – ₹692.90 · fair‑value band ₹133.97 – ₹281.58 · the ₹343.50 price screens above the ₹226.12 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) currently trades at ₹343.50, while our model-based Fair Value estimate is ₹226.12, implying the stock looks roughly 34.2% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, MEDI ASSIST HEALTHCARE SERVICES LIMITED generated revenue of ₹9.0B at a net margin of 9.7%. Revenue grew 28.1% year over year. It earns a return on equity of 12.7%. The balance sheet holds a net cash position of ₹319M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹133.97 (bear case) to ₹281.58 (bull case); at ₹343.50, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high and 17% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -3% fair-value upside, at -34%, MEDIASSIST screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (₹368.42) versus Dividend Discount (₹60.63). Highest evidence: Growth DCF (80).
Notify me when MEDIASSIST reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 25
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector.
Full company description
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. It also provides; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MEDI ASSIST HEALTHCARE SERVICES LIMITED reported revenue of ₹9.0B in FY2025 versus ₹3.9B in FY2021, a compound +23.1%/yr. Reported net income was ₹879M in FY2025, compounding +8.2%/yr from FY2021.
MEDIASSIST screens 34% overvalued. Compare with UnitedHealth Group →
Peer Group
Healthcare Plans · 15 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Healthcare Plans median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| UnitedHealth Group UNH | $405.59 | $292.06 | -28% |
| CVS Health Corporation CVS | $94.72 | $42.25 | -55% |
| Elevance Health, Inc ELV | $399.14 | $426.53 | +7% |
| The Cigna Group CI | $277.41 | $495.42 | +79% |
| Humana Inc HUM | $388.83 | $126.42 | -67% |
| Centene Corporation CNC | $67.07 | $111.96 | +67% |
| Molina Healthcare, Inc MOH | $206.06 | $199.31 | -3% |
| Oscar Health, Inc OSCR | $29.61 | $59.22 | +100% |
| Alignment Healthcare, Inc ALHC | $13.52 | $2.37 | -82% |
| Progyny, Inc PGNY | $25.42 | $16.44 | -35% |
Compare MEDI ASSIST HEALTHCARE SERVICES LIMITED with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) overvalued or undervalued?
What is the fair value of MEDIASSIST?
What is the quality score of MEDIASSIST?
What is the revenue of MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST)?
What is the net profit margin of MEDIASSIST?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MEDI ASSIST HEALTHCARE SERVICES LIMITED and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.